GENE ONLINE|News &
Opinion
Blog

2025-11-11|

Study Explores Lesser Omental Panniculitis as Rare Cause of Acute Abdominal Pain in Children

by GOAI
Share To

A recent study published in *Pediatric Radiology* examines lesser omental panniculitis as a rare cause of acute abdominal pain in children. The condition, which involves inflammation of the fatty tissue within the lesser omentum, can closely resemble more common abdominal disorders, creating challenges for accurate diagnosis. Researchers Ichiki, Tateishi, and Uchida conducted an investigation into this unusual etiology, shedding light on its clinical presentation and diagnostic complexities.

The study highlights that lesser omental panniculitis is often mistaken for other acute abdominal conditions due to overlapping symptoms such as severe pain and tenderness. This misidentification may delay appropriate treatment or lead to unnecessary interventions. The researchers emphasize the importance of imaging techniques like computed tomography (CT) scans in identifying hallmark signs of the condition, including localized fat stranding and inflammation within the lesser omentum. Their findings aim to assist clinicians in recognizing this rare but significant cause of pediatric abdominal pain and improve diagnostic accuracy moving forward.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: November 12, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
LATEST
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
Scroll to Top